Publications
- Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial2015 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Prognostic factors in renal cell carcinoma patients treated with sorafenib: results from the Czech registry2015 | First Faculty of Medicine
- Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial2015 | Publication without faculty affiliation
- Rare myxoid liposarcoma metastasis to the interventricular septum of the heart2014 | Second Faculty of Medicine
- Avastin in first-line treatment of metastatic breast cancer - our experiences: case report2013 | Second Faculty of Medicine
- Trabectedin registry2011 | Publication without faculty affiliation
- Clinical, pathological and molecular characteristics of newly diagnosed breast cancers2007 | Second Faculty of Medicine, Central Library of Charles University
- Preoperative radiotherapy for locally advanced rectal cancer and prognostic factors influencing outcome2006 | Second Faculty of Medicine
- Integrative analysis of mRNA and miRNA expression profiles and somatic variants in oxysterol signaling in early-stage luminal breast cancer2023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...
